24/7
Buzz
Startups
VC
AI
Innovation
Opinions
Events
Promising Startups 2024
BiblioTech
Boarding Pass
Corporate
Appointments
CTalk
Tech Gateways
2025 VC survey
@Finance
Ctech Testimonials
Shopping
Projects
Spotlight
About
Newsletter
Contact us
Facebook
Twitter
ACCESSIBILITY
by
Homepage
Epinephrine
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
Innovation
OPINIONS
EVENTS
SHOPPING
ABOUT
teram of use
Privacy Policy
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
09:09
CTech’s Book Review: What strategy really is and why so many organizations get it wrong
08:20
British Ambassador to Israel, Simon Walters: “If you build in Britain, we will back you”
08:03
The end-of-year tech layoffs are not a crisis - they mark a paradigm shift
07:29
MSC denies interest in acquiring ZIM
More stories
Buzz
Most popular
Daily
Weekly
1
Huang declares Israel Nvidia’s “second home” with record-breaking campus investment
2
Cyera raises $400 million at $9 billion valuation in Blackstone-led round
3
Vega raises $120 million Series B as two-year-old cyber startup hits $700 million valuation
4
“The acquisition of Armis marks a clear entry by ServiceNow into cybersecurity”
5
Dell acquires AI data-infrastructure startup Dataloop in $120 million all-cash deal
More news
Epinephrine
1 stories about Epinephrine
Teva, Mylan Drop on Announcement of Epinephrine Injector Rival
09.12.18
|
Lilach Baumer
Novartis’ U.S. division Sandoz announced a planned release for early 2019. The company will sell its drug, which lacks the EpiPen’s auto-injector, for $250 a pair out of pocket, compared to Mylan and Teva’s $300